Retraction
MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ ERK signaling pathways
Paper Information
Record ID:
51905
Author(s):
Journal:
Publication Date:
December 16, 2019
Retraction Date:
February 15, 2024
(1.8 year years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Springer - Biomed Central (BMC)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (61)
61
Total Citations4
Post-Retraction(6.6%)
57
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
0
After 2+ years
454
Days since retraction (latest)
MicroRNA nanoformulation: a promising approach to anti-tumour activity
Abhishesh Kumar Badal, Arnab Nayek, Ruby Dhar et al. (4 authors)
Investigational New Drugs
Published: May 2025
454 days after retraction
Fetal Brain-Derived Exosomal miRNAs from Maternal Blood: Potential Diagnostic Biomarkers for Fetal Alcohol Spectrum Disorders (FASDs)
Nune Darbinian, Monica Hampe, Diana Martirosyan et al. (10 authors)
International Journal of Molecular Sciences
Open Access
Published: May 2024
102 days after retraction
HER2 puzzle pieces: Non-Coding RNAs as keys to mechanisms, chemoresistance, and clinical outcomes in Ovarian cancer
Fangwei Yang, Lixiang Yan, Junnan Ji et al. (5 authors)
Pathology - Research and Practice
Published: Apr 2024
1 citation
1 citation
74 days after retraction
CircDiaph3 aggravates H/R-induced cardiomyocyte apoptosis and inflammation through miR-338-3p/SRSF1 axis
Lin Lin, Li Wang, Aimin Li et al. (5 authors)
Journal of Bioenergetics and Biomembranes
Open Access
Published: Apr 2024
4 citations
4 citations
58 days after retraction
USP7 inhibits the progression of nasopharyngeal carcinoma via promoting SPLUNC1-mediated M1 macrophage polarization through TRIM24
H.J. Liu, Ling Tang, Sha Gong et al. (8 authors)
Cell Death and Disease
Open Access
Published: Dec 2023
15 citations
15 citations
56 days before retraction
Long noncoding RNA FTX promotes epithelial-mesenchymal transition of epithelial ovarian cancer through modulating miR-7515/TPD52 and activating Met/Akt/mTOR.
Yong Li, Xinghua Zhu, Can Zhang et al. (8 authors)
PubMed
Published: Dec 2023
2 citations
2 citations
76 days before retraction
Mettl3 induced <scp>miR</scp>‐338‐3p expression in dendritic cells promotes antigen‐specific Th17 cell response via regulation of Dusp16
Yankai Wei, Chao Yang, Y Liu et al. (7 authors)
The FASEB Journal
Published: Oct 2023
10 citations
10 citations
113 days before retraction
Bruceine A: Suppressing metastasis via MEK/ERK pathway and invoking mitochondrial apoptosis in triple-negative breast cancer
Xiao Li, Changqun Liu, Xin Zhang et al. (13 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Oct 2023
11 citations
11 citations
114 days before retraction
Understanding crosstalk of organ tropism, tumor microenvironment and noncoding RNAs in breast cancer metastasis
Sohini Chakraborty, Satarupa Banerjee
Molecular Biology Reports
Published: Oct 2023
3 citations
3 citations
134 days before retraction
MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis
Aryan Rezaee, Sara Ahmadpour, Ameneh Jafari et al. (10 authors)
Frontiers in Oncology
Open Access
Published: Oct 2023
4 citations
4 citations
135 days before retraction
MACC1-induced migration in tumors: Current state and perspective
Tim Hohmann, Urszula Hohmann, Faramarz Dehghani
Frontiers in Oncology
Open Access
Published: Mar 2023
8 citations
8 citations
325 days before retraction
Pseudogene TDGF1P3 regulates the proliferation and metastasis of colorectal cancer cells via the miR-338-3p–PKM2 axis
Qianwen Ni, Min An, Shi Luo et al. (11 authors)
Biochemical and Biophysical Research Communications
Published: Nov 2022
4 citations
4 citations
451 days before retraction
The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance – A focus on signaling pathways interplay
Ahmed Ismail, Ahmed I. Abulsoud, Doaa Fathi et al. (9 authors)
Pathology - Research and Practice
Published: Nov 2022
57 citations
57 citations
457 days before retraction
Effects of Circ_0109046 Regulating Mir-338-3p on the Malignant Behavior of A2780 Cells
Yue Zhao, Haidan Diao, Jiangning Li et al. (9 authors)
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Sep 2022
1 citation
1 citation
513 days before retraction
Microsatellite instability/mismatch repair deficiency and activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland: A case report
Guang Yang
Medicine
Open Access
Published: Aug 2022
3 citations
3 citations
538 days before retraction
miRNA-338-3p inhibits the migration, invasion and proliferation of human lung adenocarcinoma cells by targeting MAP3K2
Bo Zhang, Dongchang Wang, Yuanyuan Wang et al. (4 authors)
Aging
Open Access
Published: Aug 2022
5 citations
5 citations
561 days before retraction
miRNA-651-3p regulates EMT in ovarian cancer cells by targeting ZNF703 and via the MEK/ERK pathway
Shuang Wang, Caixia Wang, Ouxuan Liu et al. (6 authors)
Biochemical and Biophysical Research Communications
Published: Jun 2022
11 citations
11 citations
609 days before retraction
Cinnamaldehyde Suppressed EGF-Induced EMT Process and Inhibits Ovarian Cancer Progression Through PI3K/AKT Pathway
Yue Wang, Ying Li, Liang Wang et al. (13 authors)
Frontiers in Pharmacology
Open Access
Published: May 2022
23 citations
23 citations
644 days before retraction
Mouse mesenchymal stem cell-derived exosomal miR-466f-3p reverses EMT process through inhibiting AKT/GSK3β pathway via c-MET in radiation-induced lung injury
Yi Li, Zhufu Shen, Xiao Jiang et al. (9 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Apr 2022
59 citations
59 citations
679 days before retraction
The Roles of MicroRNA-133 in Gynecological Tumors
Yang Zhou, Z R Cheng
Gynecology and Minimally Invasive Therapy
Open Access
Published: Apr 2022
2 citations
2 citations
685 days before retraction
Characterization of the microRNA transcriptomes and proteomics of cochlear tissue-derived small extracellular vesicles from mice of different ages after birth
Pei Jiang, Xiangyu Ma, Shanying Han et al. (12 authors)
Cellular and Molecular Life Sciences
Published: Feb 2022
18 citations
18 citations
719 days before retraction
Downregulation of miR-338-3p alleviates neuronal ischemic injury by decreasing cPKCγ-Mediated autophagy through the Akt/mTOR pathway
Haiping Wei, Zhifeng Peng, Jia Guo et al. (5 authors)
Neurochemistry International
Published: Jan 2022
6 citations
6 citations
766 days before retraction
miR-338-3p blocks TGFβ-induced myofibroblast differentiation through the induction of PTEN
A.R. Rackow, Jennifer Judge, Collynn F. Woeller et al. (5 authors)
AJP Lung Cellular and Molecular Physiology
Open Access
Published: Jan 2022
14 citations
14 citations
770 days before retraction
Mouse Mesenchymal Stem Cell-derived Exosomal Mir-466f-3p Reverses Emt Process Through Inhibiting Akt/gsk3β Pathway via C-met in Radiation-induced Lung Injury
Yi Li, Zhufu Shen, Xiaohua Jiang et al. (9 authors)
Research Square (Research Square)
Open Access
Published: Jan 2022
771 days before retraction
COA3 overexpression promotes non-small cell lung cancer metastasis by reprogramming glucose metabolism.
Hongwei Lin, Yanjun Gao, Kang Sun et al. (7 authors)
PubMed
Published: Jan 2022
8 citations
8 citations
775 days before retraction
KLF9 regulates miR-338-3p/NRCAM axis to block the progression of osteosarcoma cells
Yunlu Liu, Kuijing Han, Yulin Cao et al. (8 authors)
Journal of Cancer
Open Access
Published: Jan 2022
13 citations
13 citations
775 days before retraction
miRNA-338-3p inhibits glioma cell proliferation and progression by targeting MYT1L
Zhengtao Yu, Yan Liu, You Li et al. (8 authors)
Brain Research Bulletin
Open Access
Published: Nov 2021
19 citations
19 citations
810 days before retraction
Footprints of microRNAs in Cancer Biology
Yaashini Rajasegaran, Adam Azlan, Aliaa Arina Rosli et al. (7 authors)
Biomedicines
Open Access
Published: Oct 2021
16 citations
16 citations
849 days before retraction
Monensin suppresses cell proliferation and invasion in ovarian cancer by enhancing MEK1 SUMOylation
Shujuan Yao, Wen Wang, Bin Zhou et al. (6 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Sep 2021
20 citations
20 citations
868 days before retraction
Clinical Characteristics, Treatment Modalities, and Potential Contributing and Prognostic Factors in Patients with Bone Metastases from Gynecological Cancers: A Systematic Review
Francesca Salamanna, Anna Myriam Perrone, Deyanira Contartese et al. (8 authors)
Diagnostics
Open Access
Published: Sep 2021
5 citations
5 citations
892 days before retraction
Circular RNA circ_0008450 regulates the proliferation, migration, invasion, apoptosis and chemosensitivity of CDDP-resistant nasopharyngeal carcinoma cells by the miR-338-3p/SMAD5 axis
Lin Liu, Bin Lu, Yan Li
Anti-Cancer Drugs
Published: Aug 2021
6 citations
6 citations
918 days before retraction
Blocking circ-SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR-338-3p and regulating LIN28B
Feng Qiu, Bin Qiao, Nan Zhang et al. (7 authors)
Cancer Cell International
Open Access
Published: Aug 2021
29 citations
29 citations
924 days before retraction
Analyzing the impact of ATF3 in tumorigenesis and immune cell infiltration of ovarian tumor: a bioinformatics study
Xiaoliu Li, Panpan Liu, Xiaona Sun et al. (10 authors)
Medical Oncology
Published: Jul 2021
6 citations
6 citations
957 days before retraction
A minor review of microRNA-338 exploring the insights of its function in tumorigenesis
Qian Yi, Hanwei Cui, Yi Liao et al. (6 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: May 2021
4 citations
4 citations
1007 days before retraction
CircHIPK2 Contributes to DDP Resistance and Malignant Behaviors of DDP-Resistant Ovarian Cancer Cells Both in vitro and in vivo Through circHIPK2/miR-338-3p/CHTOP ceRNA Pathway
Yang Cao, Xin Xie, Mingzhu Li et al. (4 authors)
OncoTargets and Therapy
Open Access
Published: May 2021
28 citations
28 citations
1020 days before retraction
Pinin promotes tumor progression via activating CREB through PI3K/AKT and ERK/MAPK pathway in prostate cancer.
Xiangyu Meng, Huizhi Zhang, Yiyue Ren et al. (9 authors)
American Journal of Cancer Research
Published: Apr 2021
29 citations
29 citations
1036 days before retraction
Molecular interactions of miR-338 during tumor progression and metastasis
Meysam Moghbeli
Cellular & Molecular Biology Letters
Open Access
Published: Apr 2021
34 citations
34 citations
1044 days before retraction
miR-4461 Regulates the Proliferation and Metastasis of Ovarian Cancer Cells and Cisplatin Resistance
Lei Dou, Yi Zhang
Frontiers in Oncology
Open Access
Published: Mar 2021
16 citations
16 citations
1073 days before retraction
The role of SOX family transcription factors in gastric cancer
Asal Jalal Abadi, Ali Zarrabi, Farid Hashemi et al. (15 authors)
International Journal of Biological Macromolecules
Published: Mar 2021
63 citations
63 citations
1081 days before retraction
The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators
Sepideh Mirzaei, Ali Zarrabi, Sholeh Etehad Asnaf et al. (14 authors)
Life Sciences
Published: Jan 2021
76 citations
76 citations
1134 days before retraction
Disregulations of PURPL and MiR-338-3p Could Serve As Prognosis Biomarkers for Epithelial Ovarian Cancer
Ruitao Zhang, Tingting He, Shi Huirong et al. (7 authors)
Journal of Cancer
Open Access
Published: Jan 2021
12 citations
12 citations
1140 days before retraction
LncRNA SNHG16 Facilitates Liver Metastases of Colorectal Cancer by Modulating Circulating Tumor Cells (CTCs) Epithelial-Mesenchymal Transition (EMT) via a Positive Feedback Loop with YAP1/TEAD1 Complex
Zhenxian Xiang, Guoquan Huang, Haitao Wu et al. (11 authors)
Research Square (Research Square)
Open Access
Published: Dec 2020
1143 days before retraction
Arbutin suppresses osteosarcoma progression via <i>miR‐338‐3p</i> /MTHFD1L and inactivation of the AKT/mTOR pathway
Chengqun Wang, Xiu‐Mei Wang, Bing‐Liang Li et al. (5 authors)
FEBS Open Bio
Open Access
Published: Nov 2020
19 citations
19 citations
1198 days before retraction
<p>LncRNA CASC15 is Upregulated in Osteosarcoma Plasma Exosomes and CASC15 Knockdown Inhibits Osteosarcoma Progression by Regulating miR-338-3p/RAB14 Axis</p>
Hongliang Zhang, Jun Wang, Tingting Ren et al. (8 authors)
OncoTargets and Therapy
Open Access
Published: Nov 2020
30 citations
30 citations
1201 days before retraction
Long noncoding RNA SBF2-AS1 contributes to the growth and metastatic phenotypes of NSCLC via regulating miR-338-3p/ADAM17 axis
Qi Chen, Sheng Min Guo, Hou Qiang Huang et al. (11 authors)
Aging
Open Access
Published: Sep 2020
16 citations
16 citations
1238 days before retraction
The Role of microRNAs in Epithelial Ovarian Cancer Metastasis
Vu H. Nguyen, Chenyang Yue, Kevin Y. Du et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: Sep 2020
39 citations
39 citations
1238 days before retraction
Targeting UDP‐glucose dehydrogenase inhibits ovarian cancer growth and metastasis
Li‐Hsun Lin, Hsiu‐Chuan Chou, Shing‐Jyh Chang et al. (12 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Sep 2020
22 citations
22 citations
1256 days before retraction
Paper citing MicroRNA-338-3p suppresses ovarian cancer cells gr...
Unknown Authors
Unknown Journal
Published: Sep 2020
1260 days before retraction
circRAE1 promotes colorectal cancer cell migration and invasion by modulating miR-338-3p/TYRO3 axis
Jiabin Du, Jianhua Xu, Junxing Chen et al. (6 authors)
Cancer Cell International
Open Access
Published: Sep 2020
25 citations
25 citations
1260 days before retraction
Resveratrol Suppresses Ovarian Cancer Cell Growth and Invasion Through Upregulation of microRNA-34a
Bing Wei, Shangli Yao, Ming Gao et al. (6 authors)
Research Square (Research Square)
Open Access
Published: Aug 2020
1275 days before retraction
Quick Stats
Total Citations:
61
Years Since Retraction:
1.8 year
Open Access:
Yes
Last Checked:
Jul 24, 2025